In CML, malignant cells in chronic phase showed galectin-3 levels much higher than those in bone marrow hematopoietic cells from control subjects or acute leukemia patients. The gene discussed is LGALS3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.